Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose C Florez

Showing results (1-10 of 369) with videos related to

Pageof 37
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 6, 2014
It's not black and white: individualizing metformin treatment in type 2 diabetesJose C Florez
Diabetes|January 28, 2010
A genome-wide association study of treated A1C: a genetic needle in an environmental haystack?Jose C Florez
Diabetes|June 13, 2017
Mining the Genome for Therapeutic TargetsJose C Florez
Current Diabetes Reports|March 28, 2009
The dawn of prospective pharmacogenetic testing in type 2 diabetesJose C Florez
Current Opinion in Clinical Nutrition and Metabolic Care|June 15, 2007
The new type 2 diabetes gene TCF7L2Jose C Florez
JAMA|January 17, 2014
Insights from monogenic diabetes and glycemic treatment goals for common types of diabetesJose C Florez
Current Diabetes Reports|August 17, 2011
Does metformin work for everyone? A genome-wide association study for metformin responseJose C Florez
Diabetologia|March 12, 2017
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?Jose C Florez
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Phenotypic consequences of the peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism: the weight of the evidence in genetic association studiesJose C Florez
Diabetes|August 24, 2013
Pharmacogenetic perturbations in humans as a tool to generate mechanistic insightJose C Florez
Pageof 37

Showing results (1-10 of 369) with videos related to

Sort By:
Pageof 37
The Journal of Clinical Endocrinology and Metabolism|September 6, 2014
It's not black and white: individualizing metformin treatment in type 2 diabetesJose C Florez
Diabetes|January 28, 2010
A genome-wide association study of treated A1C: a genetic needle in an environmental haystack?Jose C Florez
Diabetes|June 13, 2017
Mining the Genome for Therapeutic TargetsJose C Florez
Current Diabetes Reports|March 28, 2009
The dawn of prospective pharmacogenetic testing in type 2 diabetesJose C Florez
Current Opinion in Clinical Nutrition and Metabolic Care|June 15, 2007
The new type 2 diabetes gene TCF7L2Jose C Florez
JAMA|January 17, 2014
Insights from monogenic diabetes and glycemic treatment goals for common types of diabetesJose C Florez
Current Diabetes Reports|August 17, 2011
Does metformin work for everyone? A genome-wide association study for metformin responseJose C Florez
Diabetologia|March 12, 2017
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?Jose C Florez
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Phenotypic consequences of the peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism: the weight of the evidence in genetic association studiesJose C Florez
Diabetes|August 24, 2013
Pharmacogenetic perturbations in humans as a tool to generate mechanistic insightJose C Florez
Pageof 37